Literature DB >> 20106667

Toward a unified nomenclature for mammalian ADP-ribosyltransferases.

Michael O Hottiger1, Paul O Hassa, Bernhard Lüscher, Herwig Schüler, Friedrich Koch-Nolte.   

Abstract

ADP-ribosylation is a post-translational modification of proteins catalyzed by ADP-ribosyltransferases. It comprises the transfer of the ADP-ribose moiety from NAD+ to specific amino acid residues on substrate proteins or to ADP-ribose itself. Currently, 22 human genes encoding proteins that possess an ADP-ribosyltransferase catalytic domain are known. Recent structural and enzymological evidence of poly(ADP-ribose)polymerase (PARP) family members demonstrate that earlier proposed names and classifications of these proteins are no longer accurate. Here we summarize these new findings and propose a new consensus nomenclature for all ADP-ribosyltransferases (ARTs) based on the catalyzed reaction and on structural features. A unified nomenclature would facilitate communication between researchers both inside and outside the ADP-ribosylation field. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106667     DOI: 10.1016/j.tibs.2009.12.003

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  317 in total

Review 1.  The role of PARP1 in the DNA damage response and its application in tumor therapy.

Authors:  Zhifeng Wang; Fengli Wang; Tieshan Tang; Caixia Guo
Journal:  Front Med       Date:  2012-06-03       Impact factor: 4.592

2.  Crystal structure of human ADP-ribose transferase ARTD15/PARP16 reveals a novel putative regulatory domain.

Authors:  Tobias Karlberg; Ann-Gerd Thorsell; Åsa Kallas; Herwig Schüler
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

3.  Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression.

Authors:  Christian Boehler; Laurent R Gauthier; Oliver Mortusewicz; Denis S Biard; Jean-Michel Saliou; Anne Bresson; Sarah Sanglier-Cianferani; Susan Smith; Valérie Schreiber; François Boussin; Françoise Dantzer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-26       Impact factor: 11.205

4.  Poly(ADP-ribose)polymerase-1 (PARP1) controls adipogenic gene expression and adipocyte function.

Authors:  Süheda Erener; Mareike Hesse; Radina Kostadinova; Michael O Hottiger
Journal:  Mol Endocrinol       Date:  2011-11-03

5.  Profiling PARP inhibitors.

Authors:  Philip Jones
Journal:  Nat Biotechnol       Date:  2012-03-07       Impact factor: 54.908

Review 6.  Formation of nuclear heterochromatin: the nucleolar point of view.

Authors:  Claudio Guetg; Raffaella Santoro
Journal:  Epigenetics       Date:  2012-06-27       Impact factor: 4.528

7.  Identification of a regulatory segment of poly(ADP-ribose) glycohydrolase.

Authors:  Davide Botta; Myron K Jacobson
Journal:  Biochemistry       Date:  2010-09-07       Impact factor: 3.162

Review 8.  Targeting of the actin cytoskeleton by insecticidal toxins from Photorhabdus luminescens.

Authors:  Alexander E Lang; Gudula Schmidt; Joel J Sheets; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-11-12       Impact factor: 3.000

9.  Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool.

Authors:  Maria Pittelli; Laura Formentini; Giuseppe Faraco; Andrea Lapucci; Elena Rapizzi; Francesca Cialdai; Giovanni Romano; Gloriano Moneti; Flavio Moroni; Alberto Chiarugi
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

10.  Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors.

Authors:  Paride Liscio; Andrea Carotti; Stefania Asciutti; Tobias Karlberg; Daniele Bellocchi; Laura Llacuna; Antonio Macchiarulo; Stuart A Aaronson; Herwig Schüler; Roberto Pellicciari; Emidio Camaioni
Journal:  J Med Chem       Date:  2014-02-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.